SCHEMBL2206145

SCHEMBL2206145

CCOS(=O)(=O)c1nc2ccccc2s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMB8 P28062 1/20 0.58
▸ PSMB5 P28074 1/20 0.58
▸ CA12 O43570 2/20 0.57
▸ CA1 P00915 2/20 0.57
▸ CA2 P00918 2/20 0.57
▸ CA4 P22748 2/20 0.57
▸ CA7 P43166 2/20 0.57
▸ CA14 Q9ULX7 2/20 0.57
▸ ALDH1A1 P00352 9/20 0.52
▸ KMT2A Q03164 6/20 0.52
▸ MAPT P10636 6/20 0.52
▸ LMNA P02545 5/20 0.52
▸ HTT P42858 5/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ SMN1; SMN2 Q16637 7/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ HSD17B10 Q99714 1/20 0.46
▸ KDM4E B2RXH2 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3595617 0.80 ALDH1A1 (0.67) PSMB8PSMB5CA12CA1CA2
SCHEMBL30149949 0.80 ALDH1A1 (0.67) PSMB8PSMB5CA12CA1CA2
SCHEMBL22079249 0.78 PSMB8 (0.58) PSMB8PSMB5CA12CA1CA2
SCHEMBL27623701 0.77 PSMB8 (0.50) PSMB8PSMB5CA12CA1CA2
SCHEMBL28689333 0.77 PSMB8 (0.57) PSMB8PSMB5CA12CA1CA2
SCHEMBL9439692 0.77 ALDH1A1 (0.56) PSMB8PSMB5CA12CA1CA2
SCHEMBL2754297 0.76 PSMB8 (0.70) PSMB8PSMB5CA12CA1CA2
SCHEMBL2711265 0.76 PSMB8 (0.75) PSMB8PSMB5CA12CA1CA2
SCHEMBL30179604 0.75 PSMB8 (0.58) PSMB8PSMB5CA12CA1CA2
SCHEMBL28332572 0.75 PSMB8 (0.58) PSMB8PSMB5CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106727147-B Draft American ginseng beautifying skin improves drug and cosmetic applications and preparation 首都医科大学附属北京中医医院 2019-11-15 — — CN disclosed
CN-106727147-A Draft American ginseng beautifying skin improves medicine and cosmetic applications and preparation 首都医科大学附属北京中医医院 2017-05-31 — — CN disclosed
EP-1926721-B1 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS MSD ITALIA SRL (IT) 2016-05-04 — — EP disclosed
US-7977374-B2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2011-07-12 — — US disclosed
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors MSD ITALIA S.R.L. (IT) 2009-06-18 — — US disclosed
EP-1926721-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. (IT) 2008-06-04 — — EP disclosed
WO-2007029035-A2 THIOPHENE AND THIAZOLE SUBSTITUTED TRIFLUOROETHANONE DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 — — WO disclosed
EP-0625551-B1 Mixtures of dyes, process for their preparation and the use thereof CIBA GEIGY AG (CH) 1999-09-29 — — EP disclosed
EP-0631008-B1 Process for the washing of printings or dyeings on cellulose containing textile materials CIBA GEIGY AG (CH) 1999-08-18 — — EP disclosed
EP-0625549-B1 Reactive dyes, process for their preparation and the use thereof CIBA GEIGY AG (CH) 1998-07-01 — — EP disclosed
EP-0485336-B1 Mixtures of reactive dyes, process for their preparation and their utilization CIBA GEIGY AG (CH) 1997-03-26 — — EP disclosed
EP-0613400-A1 TEST DEVICE COMPRISING A PLATE CONTAINING A MULTIPLICITY OF WELLS WITH AN ASSOCIATED METERING DEVICE, AS WELL AS A KIT WHICH COMPRISES THESE DEVICES AND USE OF THE DEVICES. SEED CAPITAL INVESTMENTS (NL) 1994-09-07 — — EP disclosed
WO-1993009872-A1 TEST DEVICE COMPRISING A PLATE CONTAINING A MULTIPLICITY OF WELLS WITH AN ASSOCIATED METERING DEVICE, AS WELL AS A KIT WHICH COMPRISES THESE DEVICES AND USE OF THE DEVICES SEED CAPITAL INVESTMENTS (SCI) B.V. (NL) 1993-05-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156591-A1 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors HDAC1, HDAC2, HDAC11 PSMB8 3123/4885PSMB5 1551/4885CA12 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback